Recent Updates
Recently added Catalysts

Intralipid

Phase 2

Diseases, Metabolic | Small molecule | Metabolic |Baxter International Inc.|Last Updated: Dec 31, 2014

Success Probability
Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
Premium
Market & Valuation
rNPV $3.2B
Market Size $9.4B
Revenue Basis $1.6B
Competitors 6
Premium
Trial Design
ACTIVE_CONTROLLEDDMCBiomarker
Total Trials1
Total Enrollment12
FDA Designations
No designations recorded
Clinical Trials (1)
NCT IDTitlePhaseStatusEnrollmentVelocityDesignStartCompletionLast UpdatedSitesCountries
NCT02185729Comparing Soybean Oil-Based (Intralipid) With an Olive Oil-Based (ClinOleic) Lipid Emulsion on Healthy VolunteersPHASE2 COMPLETED 12Jun 1, 2008Mar 1, 2012Dec 31, 20141 United States
Unlock Drug Trial Details
Study Endpoints
Primary Endpoints
Flow Mediated Dilation
Baseline

Endothelium-dependent brachial artery flow-mediated dilation (FMD) was assessed. Ultrasound images of the brachial artery were obtained and arterial diameters were measured with customized software. Brachial artery FMD was calculated as (hyperemic diameter - baseline diameter)/baseline diameter × 100.

Unlock Study Endpoints
Study Design & Arms
AllocationNA
MaskingNONE
ModelSINGLE_GROUP
PurposeBASIC_SCIENCE
Treatment Arms
ArmTypeDescription
Healthy VolunteerACTIVE_COMPARATORSubjects receive 24 hours of infusion of 0.9% normal saline, dextrose (sugar) without fat, ClinOleic (olive oil-based), and Intralipid (soybean-derived fat)
Interventions
NameTypeDescription
IntralipidDRUGInfusion of Intralipid (soybean-derived fat)
ClinOleicDRUGInfusion of ClinOleic (olive oil-based)
DextroseDRUGInfusion of dextrose (sugar) without fat
Saline (control)OTHERInfusion of 0.9% normal saline
Unlock Study Design Details
Eligibility Criteria
Age Range18 Years — 65 Years
SexALL
Healthy VolunteersYes
Study Sites1

Inclusion Criteria: * Healthy males or females, BMI 25 - 35 kg/m2, between the ages of 18 and 65 years Exclusion Criteria: * The patient is pregnant or breast feeding * Subjects have or with history of diabetes, hypertension, fasting triglyceride levels \> 250 mg/dL, liver disease (ALT 2.5x \> up...

Countries:United States
Unlock Eligibility Criteria